Ealing Among First Hospitals To Trial Trump's Covid Drug |
|
Ronapreve given to former President when he caught the virus A drug which has been credited with allowing Donald Trump to recover rapidly from the effects of Covid-19 is now being used to treat patients at Ealing Hospital. It is one of the first in the UK to administer Ronapreve to Covid-19 patients after trials showed that it can reduce the risk of death by 30%. The drug first made the headlines a year ago when former US President Donald Trump was given an infusion of it before clinical trials confirmed its effectiveness. The therapy involves a combination of antibodies that attach themselves to the virus to stop it infecting cells and is given to COVID patients admitted to hospital who haven’t naturally made their own antibodies. Dr Ashley Whittington, an infectious diseases consultant, said, “We initially ran a trial at the trust and a number of hospitalised patients agreed to take part and it was subsequently given emergency approval. It helps reduce hospital stays by a couple of days.” Covid patients continue to be admitted to the trust’s hospitals in Ealing and Northwick Park but in far smaller numbers than its last peak in February. The majority of admissions haven’t been vaccinated. Dr Whittington added, “The benefits of having the vaccination far outweigh the risks and my advice to anyone is to err on the side of caution to protect yourself and others.”
November 4, 2021
![]() |